Cargando…
Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients
BACKGROUND: Systemic administration of marrow stromal cells (MSCs) leads to the release of a broad range of factors mediating recovery in rodent stroke models. The release of these factors could depend on the various cell types within the peripheral blood as they contact systemically administered MS...
Autores principales: | Satani, Nikunj, Parsha, Kaushik, Davis, Courtney, Gee, Adrian, Olson, Scott D., Aronowski, Jaroslaw, Savitz, Sean I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580494/ https://www.ncbi.nlm.nih.gov/pubmed/36277912 http://dx.doi.org/10.3389/fneur.2022.958579 |
Ejemplares similares
-
Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model
por: Yang, Bing, et al.
Publicado: (2016) -
Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes
por: Satani, Nikunj, et al.
Publicado: (2020) -
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro
por: Satani, Nikunj, et al.
Publicado: (2021) -
World-Wide Efficacy of Bone Marrow Derived Mesenchymal Stromal Cells in Preclinical Ischemic Stroke Models: Systematic Review and Meta-Analysis
por: Satani, Nikunj, et al.
Publicado: (2019) -
Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke
por: Davis, Courtney, et al.
Publicado: (2021)